Leadership

Dr. Neas is the founder and creator of the Company’s technology platform and has been with the Company primarily in scientific leadership roles since 1998 when the company was originally CHATA Biosystems, Inc. CHATA’s technology is a patented packaging system for chemical delivery to analytical instruments used in pharmaceutical quality assurance laboratories. From 1994-1997, Dr. Neas was the Director of R&D and Quality Assurance for Summit Biotechnology, a wholly owned subsidiary of ConAgra Corporation. ConAgra’s technology came from processing of their animal food production into chemical products. In 1992, Dr. Neas joined the Rubbright Corporation, a small biotech consulting company, as part owner and Vice President of R&D. From 1983 to 1992, Dr. Neas held the position of principal scientist at CEM Corporation, now a large corporation developing microwave based technology for analytical chemistry. Dr. Neas was the head of research involved in development of new products. Dr. Neas began his career as Director of R&D at HyClone Laboratories from 1981 to 1983 for the development of new products. Hyclone laboratories is now owned by GE Healthcare Life Sciences and Thermo Scientific. Dr. Neas received his bachelor and master’s degrees from Texas A&M, Kingsville Texas, in Microbiology, with minors in chemistry, and his Ph.D. from Utah State University in Microbiology.  Dr. Neas is one of the inventors on eighteen issued patents, 24 pending applications, and 3 new Armis Biopharma provisional applications.